+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nuclear Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Nuclear Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Nuclear Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5952887
Free Webex Call
10% Free customization
Description Jump to:

Institutional is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Nuclear Pharmacy Market, valued at USD 5.99 Billion in 2024, is projected to experience a CAGR of 7.92% to reach USD 9.46 Billion by 2030. Nuclear pharmacy involves the preparation and dispensing of radioactive materials for patient administration in nuclear medicine, utilizing radiopharmaceuticals for diagnostic and therapeutic purposes. Market growth is driven by the increasing prevalence of chronic diseases like cancer and cardiovascular disorders, advancements in nuclear medicine technologies, and a growing demand for personalized medicine, expanding applications across oncology and neurology.

Key Market Drivers

The global nuclear pharmacy market is significantly influenced by two major driving factors: the rising burden of chronic diseases and continuous advancements in radiopharmaceutical development. The increasing global burden of chronic diseases represents a primary impetus for the nuclear pharmacy market, necessitating sophisticated diagnostic and therapeutic interventions. Conditions like cancer, cardiovascular disorders, and neurodegenerative diseases exhibit growing prevalence worldwide, driving escalating demand for early, accurate detection and targeted treatment. Nuclear medicine, offering functional and molecular imaging, proves crucial in disease staging, treatment monitoring, and personalized therapy selection.

Key Market Challenges

A significant challenge impeding the Global Nuclear Pharmacy Market's growth is the persistent supply chain disruptions and shortages of critical radioisotopes. The inherently short half-lives of these materials, such as Technetium-99m, necessitate complex and highly efficient logistics, making the supply chain exceptionally vulnerable to any interruption in production or distribution. This reliance on a limited number of aging nuclear reactors for isotope generation, coupled with unpredictable maintenance schedules or unexpected outages, frequently leads to insufficient supply.

Key Market Trends

The emergence of targeted alpha therapies significantly influences the global nuclear pharmacy market by introducing a potent and precise cancer treatment modality. These therapies deliver highly localized radiation using alpha-emitting isotopes, effectively targeting malignant cells with minimal damage to healthy tissues, thus expanding therapeutic options. In January 2025, a Society of Nuclear Medicine and Molecular Imaging (SNMMI) strategy meeting indicated two-thirds of physicians anticipated over 10% growth in therapy at their facilities within the year. This is reinforced by Sanofi's AlphaMedix (Lead-212-DOTAMTATE) receiving FDA Breakthrough Therapy Designation in February 2024, followed by positive Phase 2 results for gastroenteropancreatic neuroendocrine tumors in October 2025.

Key Market Players Profiled:

  • Jubilant Radiopharma (Jubilant Pharma Holdings Inc.)
  • GE HealthCare Technologies, Inc.
  • Cardinal Health, Inc.
  • ARTMS Inc.
  • AnazaoHealth Corp.
  • Sofie Biosciences, Inc.
  • Pacific Radiopharmacy, Ltd.
  • NTP Radioisotopes SOC Ltd.
  • Lantheus Medical Imaging, Inc.
  • ANSTO Nuclear Medicine Pty Ltd.

Report Scope:

In this report, the Global Nuclear Pharmacy Market has been segmented into the following categories:

By Type:

  • Institutional
  • Commercial

By Purpose:

  • Diagnostic
  • Therapeutic

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nuclear Pharmacy Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Nuclear Pharmacy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Institutional, Commercial)
5.2.2. By Purpose (Diagnostic, Therapeutic)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Nuclear Pharmacy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Purpose
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Nuclear Pharmacy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Purpose
6.3.2. Canada Nuclear Pharmacy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Purpose
6.3.3. Mexico Nuclear Pharmacy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Purpose
7. Europe Nuclear Pharmacy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Purpose
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Nuclear Pharmacy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Purpose
7.3.2. France Nuclear Pharmacy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Purpose
7.3.3. United Kingdom Nuclear Pharmacy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Purpose
7.3.4. Italy Nuclear Pharmacy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Purpose
7.3.5. Spain Nuclear Pharmacy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Purpose
8. Asia-Pacific Nuclear Pharmacy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Purpose
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Nuclear Pharmacy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Purpose
8.3.2. India Nuclear Pharmacy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Purpose
8.3.3. Japan Nuclear Pharmacy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Purpose
8.3.4. South Korea Nuclear Pharmacy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Purpose
8.3.5. Australia Nuclear Pharmacy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Purpose
9. Middle East & Africa Nuclear Pharmacy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Purpose
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Nuclear Pharmacy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Purpose
9.3.2. UAE Nuclear Pharmacy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Purpose
9.3.3. South Africa Nuclear Pharmacy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Purpose
10. South America Nuclear Pharmacy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Purpose
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Nuclear Pharmacy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Purpose
10.3.2. Colombia Nuclear Pharmacy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Purpose
10.3.3. Argentina Nuclear Pharmacy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Purpose
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Nuclear Pharmacy Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Jubilant Radiopharma (Jubilant Pharma Holdings Inc.)
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. GE HealthCare Technologies, Inc.
15.3. Cardinal Health, Inc.
15.4. ARTMS Inc.
15.5. AnazaoHealth Corp.
15.6. Sofie Biosciences, Inc.
15.7. Pacific Radiopharmacy, Ltd.
15.8. NTP Radioisotopes SOC Ltd.
15.9. Lantheus Medical Imaging, Inc.
15.10. ANSTO Nuclear Medicine Pty Ltd.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Nuclear Pharmacy market report include:
  • Jubilant Radiopharma (Jubilant Pharma Holdings Inc.)
  • GE HealthCare Technologies, Inc.
  • Cardinal Health, Inc.
  • ARTMS Inc.
  • AnazaoHealth Corp.
  • Sofie Biosciences, Inc.
  • Pacific Radiopharmacy, Ltd.
  • NTP Radioisotopes SOC Ltd.
  • Lantheus Medical Imaging, Inc.
  • ANSTO Nuclear Medicine Pty Ltd.

Table Information

Report AttributeDetails
No. of Pages185
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.99 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.46 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Nuclear Pharmacy Market - Global Strategic Business Report - Product Image

Nuclear Pharmacy Market - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
E-Pharmacy Market Report 2025 - Product Image

E-Pharmacy Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Pharmacy Benefit Management Market Report 2025 - Product Image

Pharmacy Benefit Management Market Report 2025

  • Report
  • 200 Pages
  • Global
From
ePharmacy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

ePharmacy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 193 Pages
  • Global
From
Retail Pharmacy De-identified Health Data Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Retail Pharmacy De-identified Health Data Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From

About the Market

In the pharmaceutical industry, nuclear pharmacy represents a specialized niche centered around the preparation and dispensing of radiopharmaceuticals. Radiopharmaceuticals are unique medications containing radioactive isotopes used in the field of nuclear medicine, primarily for diagnostic imaging and therapy. Nuclear pharmacies are responsible for compounding and preparing these substances in a way that ensures both the safety and the efficacy of the medications for patients undergoing various types of scans, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), as well as for certain therapeutic purposes. These pharmacies adhere to stringent regulatory requirements due to the radioactive nature of the materials handled. Pharmacists in this field require additional training and certification to handle and dispense radiopharmaceuticals. The services offered by nuclear pharmacies are essential for hospitals and diagnostic centers that do not have the facilities to produce or store radiopharmaceuticals on site. Consequently, nuclear pharmacy services bridge the gap by delivering dose-specific radiopharmaceuticals to these medical facilities in time for scheduled patient procedures. Some prominent companies operating in the nuclear pharmacy market include Cardinal Health, GE Healthcare, Siemens Healthineers, and Advanced Accelerator Applications (a Novartis company). These firms specialize in the production and distribution of radiopharmaceuticals, providing necessary products and services to healthcare providers in the field of nuclear medicine. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.